OpTier Announces Impending Launch of Highly Anticipated APM SaaS Product

OpTier Announces Impending Launch of Highly Anticipated APM SaaS Product

NEW YORK, NY — (Marketwired) — 04/22/13 — , the leader in Application Performance Management (APM) and end-to-end Big Data Analytics, announced today the imminent launch of "OpTier SaaS," the company-s new cloud-based, analytics driven enterprise class APM solution."OpTier SaaS," based on the company-s award-winning OpTier APM on-premise solution, will formally launch April 30th. The company has been offering a () of "OpTier SaaS" to existing enterprise custome

Infor Announces Cloud Initiative Using Amazon Web Services to Tackle Big Data With Amazon Redshift

Infor Announces Cloud Initiative Using Amazon Web Services to Tackle Big Data With Amazon Redshift

NEW YORK, NY — (Marketwired) — 04/22/13 — , a leading provider of business application software serving more than 70,000 customers, today announced Infor Sky Vault a big data initiative that leverages , micro-vertical expertise, and beautiful dashboards developed by Infor ION BI experts and designed by Hook & Loop, Infor-s Manhattan-based in-house design agency.Corporate data is fragmented across diverse commercial, legacy, and custom applications. Using ION, customers can extract transa

MMRGlobal Awarded Another International Patent to Fight Cancer, Company Benefits From Worldwide HIT & Biotech Patents

MMRGlobal Awarded Another International Patent to Fight Cancer, Company Benefits From Worldwide HIT & Biotech Patents

LOS ANGELES, CA — (Marketwired) — 04/22/13 — (OTCQB: MMRF) ("MMR") today announced that the Australian Patent Office has issued a Notice of Allowance (NOA) for the Company-s anti-CD20 monoclonal antibody assets, #2007338607, under the title, "Antibodies and Methods for Making and Using Them." The patent application was originally filed on September 14, 2007. The Australian NOA is significant to the Company in that it reinforces the value of the U.S. antibody patent that

1 78 79 80 81 82 227